Heart Failure (HFrEF)

Cardiovascular · ~11% of blueprint
Pathophysiology
Reduced contractility (EF ≤40%) → ↓CO → neurohormonal (RAAS/SNS) activation → volume overload & remodeling.
Signs & Symptoms
Dyspnea on exertion, orthopnea, PND, bilateral crackles, JVD, S3 gallop, peripheral edema.
Gold Standard Diagnosis
Echocardiography (assesses EF). BNP/NT-proBNP supports dx and tracks severity.
First-line Treatment
GDMT: ARNI (or ACEi/ARB) + beta-blocker + MRA + SGLT2 inhibitor; loop diuretic for congestion.
High-Yield Pearl

The 4 pillars (ARNI, BB, MRA, SGLT2i) reduce mortality. Diuretics treat symptoms, not mortality.

Practice this

Learn it in your courses

Sources

Reviewed September 2026
  1. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure — AHA/ACC/HFSA, 2022
  2. StatPearls: Heart Failure — NCBI Bookshelf / StatPearls, 2025
  3. StatPearls: Heart Failure — Table 2, Classification of HF by LVEF — NCBI Bookshelf / StatPearls, 2025

Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.

More Cardiovascular conditions

Got your lecture on Heart Failure (HFrEF)? Turn it into flashcards and board-style questions, free. Drop it on the home page

All Cardiovascular